Skip to content

Voyager Life PLC - Completion of acquisition of Amphora Health


Announcement provided by

Voyager Life plc · VOY

07/03/2024 07:00

Voyager Life PLC - Completion of acquisition of Amphora Health
RNS Number : 9031F
Voyager Life PLC
07 March 2024
 

 

7 March 2024

 

Voyager Life plc

 

("Voyager" or the "Company") 

 

Completion of acquisition of Amphora Health

 

Voyager, the health and wellness group formulating, manufacturing and supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, is pleased to announce that, further to the announcement of 30 January 2024, it has completed its acquisition of Amphora Health Ltd ("Amphora"), owner of the Amphora and Infused Amphora brands.

 

Over the coming months, Voyager expects to commence manufacturing of Amphora branded products, primarily its range of CBD oils and vapour products.  The CBD oils are validated on the FSA's novel foods list and vapour products represents a new product listing for Voyager.  As previously announced in respect of forthcoming changes in UK legislation, Amphora vapour products are not disposable but are currently sold in cartridges for use with a rechargeable battery.  Furthermore Voyager intends to supply the formula as an e-liquid for customers to refill their preferred vapour products themselves.

 

Amphora's current inventories which are estimated by Voyager to have a value in excess of £50,000 (at cost) will be sold through the Company's current sales channels, including its three own stores and its website.

 

The consideration payable for Amphora has been satisfied through the issue of 416,666 new ordinary shares of £0.01 each in Voyager at a price of 12 pence per share (approximately £50,000) in aggregate to Amphora's shareholders.  In addition, a further 416,666 new ordinary shares at a price of 12 pence per share may be issued in the event, inter alia, that sales of Amphora or Infused Amphora branded products exceed £100,000 over the 24 month period from completion.

 

Admission

 

Application has been made for 416,666 new ordinary shares to be admitted to trading on the Aquis Stock Exchange Growth Market ("Admission"). Admission is expected to occur at 8:00 am on or around 13 March 2023. The new ordinary shares will rank pari passu with the existing ordinary shares.

 

Total Voting Rights

 

Following Admission, the Company's enlarged share capital will comprise 14,402,910 ordinary shares ordinary shares of 1 pence each. Therefore, the total number of voting rights in the Company will be 14,402,910. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

ENDS

 

Enquiries:

Voyager Life plc

 

Nick Tulloch, CEO

 

 

 

Tel: +44 (0) 1738 317 693

 

http://voyagerlife.uk

nick@voyagerlife.uk

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

 

Ludovico Lazzaretti/Liam Murray

 

Tel: +44 (0) 20 7213 0880

Stanford Capital Partners LLP (Broker)

 

Patrick Claridge  

 

Bob Pountney

 

 

+44 (0) 203 3650 3650

 

+44 (0) 203 3650 3651

 

 

 

 

Notes to Editors:

 

About Voyager

Voyager was founded in 2020 and is based in Perth, Scotland.  The Company's primary objective is the formulation, manufacture and supply of high quality CBD and hemp seed oil products although it also produces several other complementary products, the majority of which are manufactured from the hemp plant.  Its product categories include a pet range which has rapidly developed into one of the Company's best sellers.   The Company sells online, through third party stores and in its own stores which are located in St Andrews, Edinburgh and Dundee.  The Company has three principal retail brands: Voyager, focused on health & wellness and petcare; Ascend Skincare, its beauty range; and Amphora, with 23 products validated on the FSA's novel foods list and a range of vapes.  Voyager products are currently available from Cornwall to Shetland in online and brick-and-mortar outlets.

 

The Company's philosophy of plant-based health and wellness is embodied in its mission statement and hashtag of "Choose you". With an experienced team and a product line created in line with the UK's regulatory regime, Voyager aims to become the trusted brand in this increasingly popular health and wellness space.

 

Through Voyager's bespoke skincare product creation and development division, voyagerCann, the Company also offers a full turnkey service to other CBD, skincare and cosmetics brands assisting them in developing and launching new products with a manufacturing and distribution facility in Scotland.

 

Website and social media links:

Voyager:

https://voyagercbd.com/

https://www.instagram.com/voyagercbd/

https://twitter.com/voyagercbd

https://www.linkedin.com/company/voyager-cbd/

https://www.facebook.com/voyagercbd/

 

voyagerCann:

https://voyagercann.com/

https://www.instagram.com/voyagercann/

https://twitter.com/voyagercann/

https://www.linkedin.com/company/voyagercann/

https://www.facebook.com/voyagercann/

 

Amphora:

https://www.infusedamphora.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEAEDKEEPLEAA]]>

View more ...

VOY announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal